Barclays PLC Has $67,000 Stake in American Well Co. (NYSE:AMWL)

Barclays PLC lessened its holdings in shares of American Well Co. (NYSE:AMWL - Free Report) by 95.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,108 shares of the company's stock after selling 140,251 shares during the quarter. Barclays PLC's holdings in American Well were worth $67,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Renaissance Technologies LLC increased its stake in shares of American Well by 63.9% in the second quarter. Renaissance Technologies LLC now owns 6,833,500 shares of the company's stock worth $2,220,000 after acquiring an additional 2,665,300 shares during the last quarter. Point72 DIFC Ltd increased its position in American Well by 1,418.5% in the 2nd quarter. Point72 DIFC Ltd now owns 103,457 shares of the company's stock worth $34,000 after purchasing an additional 96,644 shares during the last quarter. Cubist Systematic Strategies LLC raised its stake in shares of American Well by 7,673.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company's stock worth $60,000 after purchasing an additional 181,715 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its holdings in shares of American Well by 2,690.2% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 419,841 shares of the company's stock valued at $136,000 after buying an additional 404,794 shares during the last quarter. Finally, AQR Capital Management LLC grew its stake in shares of American Well by 28.1% in the 2nd quarter. AQR Capital Management LLC now owns 1,895,730 shares of the company's stock valued at $616,000 after buying an additional 416,387 shares in the last quarter. Institutional investors and hedge funds own 56.05% of the company's stock.

American Well Stock Performance

Shares of American Well stock traded up $0.03 on Friday, reaching $11.00. The stock had a trading volume of 35,604 shares, compared to its average volume of 55,169. The business's 50-day moving average price is $8.58 and its two-hundred day moving average price is $8.84. The stock has a market cap of $168.49 million, a P/E ratio of -0.75 and a beta of 1.11. American Well Co. has a fifty-two week low of $5.00 and a fifty-two week high of $29.00.

Analyst Ratings Changes

A number of research firms have issued reports on AMWL. Needham & Company LLC reiterated a "hold" rating on shares of American Well in a research note on Thursday, October 31st. Morgan Stanley cut their price target on shares of American Well from $20.00 to $10.50 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Finally, Wells Fargo & Company upgraded shares of American Well from an "equal weight" rating to an "overweight" rating and set a $15.00 price objective for the company in a report on Monday, January 13th.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.